BioSpace News Archive

Mammograms are an essential part of preventive healthcare, and when an initial review reveals a suspicious lesion, additional imaging and/or invasive breast biopsies could be the next step in diagnosis.

Amneal Pharmaceuticals, Inc. announced that a delegation of senior members of the U.S. Department of Health and Human Services and U.S. Food and Drug Administration together with local government officials recently visited the Company’s manufacturing facility in Matoda, India.

Vir Biotechnology, Inc. announced that management will be participating in the following upcoming investor conferences during the month of September.

$48.7 million in cash and cash equivalents at June 30, 2023, providing expected runway to advance Company’s development candidate (“DC”) through Phase I clinical development in healthy human volunteers and Duchenne muscular dystrophy patients

Celularity Inc. (Nasdaq: CELU) (Celularity), a biotechnology company developing allogeneic cell therapies and biomaterial products, announced today a multi-year Research Collaboration Services Agreement with Regeneron Pharmaceuticals, Inc. (Regeneron) to support the research of Regeneron’s allogeneic cell therapy candidates.

Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) (“Britannia” or the “Company”) is pleased to provide its unaudited financial results for the three months ended June 30, 2023. These filings and additional information regarding Britannia are available for review on SEDAR at www.sedar.com.

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) today announced the publication of a manuscript reporting on the ability of Shuttle’s lead Histone deacetylase 6 (HDAC6) inhibitor drug candidate (SP-2-225) to stimulate the innate immune system following radiation therapy.

Vertex Pharmaceuticals Incorporated announced that E. Morrey Atkinson, Ph.D., has been appointed Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations, effective immediately.

Global health company The Cigna Group (NYSE: CI) announced today that David Cordani, chairman and chief executive officer, will present at the Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023 in New York, NY.

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023.